Novavax (NVAX)

Company Description

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates.


 

COMPANY ADDRESS
9920 Belward Campus Drive
Rockville, Maryland 20850
United States

COMPANY PHONE
240-268-2000

COMPANY WEBSITE



Get BioInvest's perspective on Novavax's CEO


Latest Company News

Most dynamic stock update: KB Home (KBH), Novavax, Inc. (NVAX) The USA Commerce - 13 hours ago On the close of 04/26/2017 KB Home (NYSE:KBH) jumped 3.57% to hit $21.17. During the session shares stayed in the range from $21.35 to $20.43. [...]
Thu, Apr 27, 2017 4:18:00 PM, Continue reading at the source
Checking the Numbers for Novavax, Inc. (NASDAQ:NVAX) BVN - 15 hours ago Novavax, Inc. (NASDAQ:NVAX) has a current Value Composite Score of 99. Using a scale from 0 to 100, a lower score would represent an undervalued company and a higher score would indicate an expensive or overvalued company. [...]
Thu, Apr 27, 2017 2:15:00 PM, Continue reading at the source
Crazy Volume Spikes for: Novavax, Inc. (NVAX) HugoPress - 15 hours ago Cantor Fitzgerald Initiates Coverage OnNovavax, Inc. (NVAX)'s stock to Neutral with the price target of $2. This rating was issued on 12/16/16. [...]
Thu, Apr 27, 2017 1:47:00 PM, Continue reading at the source
Unusual Volume Spikes For: Novavax, Inc. (NASDAQ:NVAX) HugoPress - 17 hours ago Cantor Fitzgerald Initiates Coverage On Novavax, Inc. (NASDAQ:NVAX)'s stock to Neutral with the price target of $2. [...]
Thu, Apr 27, 2017 12:34:00 PM, Continue reading at the source
Two sizzlers stock's are not to be missed: Novavax, Inc. (NVAX), Exelon Corp ... StockNewsJournal - 17 hours ago Exelon Corporation (NYSE:EXC) market capitalization at present is $32.69B at the rate of $34.90 a share. The firm's price-to-sales ratio was noted 1.04 in contrast with an overall industry average of 0.96. [...]
Thu, Apr 27, 2017 12:33:00 PM, Continue reading at the source
Earnings Clues on Novavax, Inc. (NVAX), Biogen Inc. (BIIB) Analyst's Predictions StockNewsJournal - Apr 26, 2017 Novavax, Inc. (NVAX) have shown a high EPS growth of -43.40% in the last 5 years and has earnings decline of -72.80% yoy. Citigroup Downgrade its coverage for Novavax, Inc. (NVAX) - StandardOracle West (WSTC) Reaches $26.78 52-Week High; Novavax, Inc. (NVAX) Had 2 Bulls - Wolcott Daily [...]
Wed, Apr 26, 2017 7:18:00 PM, Continue reading at the source
Revenue Approximations Analysis: CBL & Associates Properties, Inc. (CBL ... StockNewsJournal - Apr 25, 2017 Novavax, Inc. (NVAX) have shown a high EPS growth of -43.40% in the last 5 years and has earnings decline of -72.80% yoy. Investment Research Analysts Opinion: Novavax, Inc. (NVAX), CBL & Associates ... - W News [...]
Tue, Apr 25, 2017 1:41:00 PM, Continue reading at the source
Novavax Inc (NASDAQ:NVAX): A Make Or Break Runner Insider Financial - Apr 11, 2017 At the beginning of March we took this look at Novavax Inc (NASDAQ:NVAX), suggesting that while it was by no means a risk free allocation, there may be some value in taking a punt on some upcoming data. Novavax, Inc. Posted gains of 0.01% in the Last Trade - Free Observer [...]
Tue, Apr 11, 2017 2:15:00 PM, Continue reading at the source
Novavax Will Ride High On RSV Vaccine Wave In 2017 Seeking Alpha - Apr 10, 2017 Late-stage investigational candidate, RSV F Maternal Vaccine, is well-positioned to capture a significant share of the $770 million infant RSV market. [...]
Mon, Apr 10, 2017 5:37:00 PM, Continue reading at the source
The Waiting Game Crushed Novavax, Inc. in March, Sending Shares Down 15% Motley Fool - Apr 5, 2017 Shares of Novavax (NASDAQ:NVAX), a clinical-stage biotechnology company focused on the development of vaccines and adjuvants, continued its steady and slippery downward decline in March. Novavax Inc. (NVAX) Plunges 12.54% on April 06 - Equities.com [...]
Wed, Apr 05, 2017 2:48:00 PM, Continue reading at the source